CD34 and metachromatic leukodystrophy: The latest published report from a clinical study (NCT01560182) included data from 29 children with presymptomatic or early symptomatic MLD who received transplantation of genetically modified CD34+ expressing ARSA at a rate of 4.2–25.9 × 106/kg, with a transduction efficiency of 61–100%.